The P48T germline mutation and polymorphism in the CDKN2A gene of patients with melanoma

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• The CDKN2A gene is a key melanoma susceptibility gene.
• Mutations in CDKN2A can disrupt cell cycle regulation, leading to abnormal cell growth and potentially cancer.
• Hereditary cancer syndromes, including those associated with melanoma, are often linked to specific gene mutations.

Purpose of the Study:

• To investigate the prevalence of germline mutations in the CDKN2A gene in patients with clinical criteria for hereditary cancer.
• To identify specific mutations and their association with family history and melanoma risk.
• To explore the potential for mutational hotspots or founder effects within the CDKN2A gene.

Main Methods:

• Secondary structural content prediction was used for mutation scanning in the CDKN2A gene.
• Sequencing was performed on samples showing alterations in electrophoretic mobility.
• Genetic analysis was conducted on 22 patients meeting criteria for hereditary cancer.

Main Results:

• A CDKN2A mutation prevalence of 4.5% (1/22 patients) was observed.
• The P48T mutation was identified in a patient with a strong family history of melanoma, predominantly in Italian kindreds.
• A high prevalence (59.1%) of polymorphisms in the 3' untranslated region of exon 3 was detected, with specific alleles (500 C/G, 540 C/T) potentially associated with melanoma risk.

Conclusions:

• The findings suggest a potential mutational hotspot or founder mutation for CDKN2A, particularly within Italian populations.
• The identified polymorphisms in the 3' untranslated region of CDKN2A may contribute to melanoma susceptibility.
• Further research is warranted to elucidate the role of CDKN2A mutations and polymorphisms in hereditary melanoma.